Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
S-8

Securities offered to employees pursuant to employee benefit plans

 View HTML
0001104659-23-023067.pdf
0001104659-23-023067.rtf
0001104659-23-023067.xls
8-K

Report of unscheduled material events or corporate event

 View HTML
0001104659-23-022618.pdf
0001104659-23-022618.rtf
0001104659-23-022618.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

 View HTML
0001558370-23-001465.pdf
0001558370-23-001465.rtf
0001558370-23-001465.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
SC 13G/A

An amendment to the SC 13G filing

 View HTML
0000080255-23-002632.pdf
0000080255-23-002632.rtf
8-K

Report of unscheduled material events or corporate event

 View HTML
0001104659-23-017984.pdf
0001104659-23-017984.rtf
0001104659-23-017984.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
SC 13G/A

An amendment to the SC 13G filing

 View HTML
0000315066-23-001415.pdf
0000315066-23-001415.rtf
SC 13G/A

An amendment to the SC 13G filing

 View HTML
0001104659-23-015479.pdf
0001104659-23-015479.rtf
SC 13G/A

An amendment to the SC 13G filing

 View HTML
0000846087-23-000085.pdf
0000846087-23-000085.rtf
0000846087-23-000085.xls
SC 13G/A

An amendment to the SC 13G filing

 View HTML
0001306550-23-004167.pdf
0001306550-23-004167.rtf
SC 13G/A

An amendment to the SC 13G filing

 View HTML
0001306550-23-000649.pdf
0001306550-23-000649.rtf